Impact of sample preparation upon intracellular metabolite measurements in 3D cell culture systems.


Journal

Metabolomics : Official journal of the Metabolomic Society
ISSN: 1573-3890
Titre abrégé: Metabolomics
Pays: United States
ID NLM: 101274889

Informations de publication

Date de publication:
12 06 2019
Historique:
received: 03 01 2019
accepted: 29 05 2019
entrez: 14 6 2019
pubmed: 14 6 2019
medline: 22 5 2020
Statut: epublish

Résumé

Interest in cell culture metabolomics has increased greatly in recent years because of its many potential applications and advantages (e.g., in toxicology). The first critical step for exploring the cellular metabolome is sample preparation. For metabolomics studies, an ideal sample preparation would extract a maximum number of metabolites and would enable reproducible, accurate analysis of a large number of samples and replicates. In addition, it would provide consistent results across several studies over a relatively long time frame. This study was conducted to evaluate the impact of sample preparation strategies on monitoring intracellular metabolite responses, highlighting the potential critical step(s) in order to finally improve the quality of metabolomics studies. The sample preparation strategies were evaluated by calculating the sample preparation effect, matrix factor, and process efficiency (PE) for 16 tobacco exposition-related metabolites, including nicotine, nicotine-derived nitrosamine ketone, their major metabolites, and glutathione, using isotopically-labelled internal standards. Samples were analyzed by liquid chromatography (LC) coupled to high-resolution mass spectrometry (HRMS). A sample drying step increased losses or variability for some selected metabolites. By avoiding evaporation, good sample preparation recovery was obtained for these compounds. For some metabolites, the cell or culture type impacted PE and matrix factor. In our sample preparation protocol, the drying-reconstitution step was identified as the main cause of metabolite losses or increased data variability during metabolomics analysis by LC-HRMS. Furthermore, PE was affected by the type of matrix. Isotopologue internal standards fully compensate losses or enhancements.

Identifiants

pubmed: 31190156
doi: 10.1007/s11306-019-1551-0
pii: 10.1007/s11306-019-1551-0
pmc: PMC6561993
doi:

Substances chimiques

Nicotine 6M3C89ZY6R
Glutathione GAN16C9B8O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

92

Références

Food Chem Toxicol. 2018 Aug;118:198-203
pubmed: 29751076
Food Chem Toxicol. 2017 Mar;101:15-35
pubmed: 28025120
Am J Physiol Lung Cell Mol Physiol. 2011 Jan;300(1):L25-31
pubmed: 20971803
Biosci Rep. 2015 May 07;35(3):
pubmed: 26182370
Front Plant Sci. 2015 Feb 17;6:49
pubmed: 25741348
Anal Bioanal Chem. 2011 Jan;399(3):1127-39
pubmed: 21125262
Bioanalysis. 2017 Sep;9(17):1329-1340
pubmed: 28901168
Metabolites. 2017 Nov 16;7(4):
pubmed: 29144418
Electrophoresis. 2018 Jul;39(13):1527-1542
pubmed: 29660150
Metabolomics. 2018;14(4):44
pubmed: 29527143
Eur J Pharm Biopharm. 2018 Sep;130:128-142
pubmed: 29894817
Methods Mol Biol. 2002;188:115-37
pubmed: 11987537
J Pharm Biomed Anal. 2018 Jan 5;147:149-173
pubmed: 28823764
Metabolomics. 2018;14(6):72
pubmed: 29805336
Regul Toxicol Pharmacol. 2016 Nov 30;81 Suppl 2:S123-S138
pubmed: 27818347
Anal Bioanal Chem. 2013 Jun;405(15):5279-89
pubmed: 23604415
J Proteomics Bioinform. 2015 Jun;8(6):126-132
pubmed: 26401069
Anal Chem. 2013 Jul 16;85(14):6876-84
pubmed: 23781873
J Cell Physiol. 2015 Jan;230(1):16-26
pubmed: 24912145
Metabolites. 2017 Oct 23;7(4):
pubmed: 29065530
ALTEX. 2014;31(4):441-77
pubmed: 25027500
Anal Chim Acta. 2018 Dec 11;1037:338-350
pubmed: 30292310
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2013;30(9):1598-605
pubmed: 23802692
Analyst. 2017 Dec 18;143(1):16-20
pubmed: 29215666
J Proteome Res. 2018 Aug 3;17(8):2611-2622
pubmed: 29939029
MethodsX. 2014 Jul 18;1:74-80
pubmed: 26150938
Chem Res Toxicol. 2017 Apr 17;30(4):870-882
pubmed: 28362102
Curr Metabolomics. 2013;1(1):92-107
pubmed: 26078916
Toxicol In Vitro. 2017 Mar;39:29-51
pubmed: 27865774
Toxicol In Vitro. 2015 Aug;29(5):864-75
pubmed: 25863282

Auteurs

Caroline Mathon (C)

PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland. Caroline.Mathon@chuv.ch.
Unit of Toxicology, CURML, Lausanne-Geneva, Switzerland. Caroline.Mathon@chuv.ch.

David Bovard (D)

PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.

Quentin Dutertre (Q)

PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.

Sandra Sendyk (S)

PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.

Mark Bentley (M)

PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.

Julia Hoeng (J)

PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.

Arno Knorr (A)

PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH